Physician profile
Glenn Werneburg
NPI 1699272229
$4,900.33
in general payments reported to CMS, 2019-2025
7 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $49.83 · 2023: $356 · 2024: $3,008 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,679 · Food and Beverage: $2,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,679.46 |
| Food and Beverage | $2,056.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,689.64 | 2023-2025 | Lumenis Pulse 120h, Axonics, Ams 700 Cxr Rte Kit |
| Medtronic, INC. | $1,605.06 | 2023-2025 | Interstim |
| Coloplast Corp | $232.72 | 2023-2024 | Titan |
| Olympus America INC. | $145.92 | 2024 | Itind System |
| Baxter Healthcare | $114.54 | 2021 | |
| Sumitomo Pharma America, INC. | $62.62 | 2025 | Gemtesa |
| Allergan, INC. | $49.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Werneburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.